Matches in Nanopublications for { ?s ?p "[Cenersen, an oligonucleotide targeting TP53, has been shown to abrogate the activity of TP53 gain-of-function mutants and to increase sensitivity of lymphoma cells to cytotoxic chemotherapy in vitro.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine."@en ?g. }
Showing items 1 to 3 of
3
with 100 items per page.
- NP750642.RAfotPglhaX3cMRO_MGkLYM9L6KYivt-N0wdDTM7IXbbg130_assertion description "[Cenersen, an oligonucleotide targeting TP53, has been shown to abrogate the activity of TP53 gain-of-function mutants and to increase sensitivity of lymphoma cells to cytotoxic chemotherapy in vitro.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP750642.RAfotPglhaX3cMRO_MGkLYM9L6KYivt-N0wdDTM7IXbbg130_provenance.
- assertion description "[Cenersen, an oligonucleotide targeting TP53, has been shown to abrogate the activity of TP53 gain-of-function mutants and to increase sensitivity of lymphoma cells to cytotoxic chemotherapy in vitro.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." provenance.
- NP915679.RArBGl5nWQbjQXX2mD4aoJEDGn0FhMY7WXzYi_GpYL76c130_assertion description "[Cenersen, an oligonucleotide targeting TP53, has been shown to abrogate the activity of TP53 gain-of-function mutants and to increase sensitivity of lymphoma cells to cytotoxic chemotherapy in vitro.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP915679.RArBGl5nWQbjQXX2mD4aoJEDGn0FhMY7WXzYi_GpYL76c130_provenance.